Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).
GSK plc has repurchased 420,000 ordinary shares at a volume‑weighted average price of 2,231.39 pence per share on 17 February 2026 under its existing share buyback programme, acting through broker BNP Paribas SA. The shares will be held in treasury, lifting treasury holdings to 240,311,094 shares and leaving 4,075,831,475 shares in issue, which reduces free‑float and concentrates voting rights among remaining shareholders.
Following this transaction, GSK reports total voting rights of 4,075,831,475, with 5.90% of voting rights now attributable to treasury shares. The move underscores the company’s continued capital‑return strategy and may signal management’s confidence in the valuation, while giving investors updated denominators for regulatory disclosure thresholds under U.K. transparency rules.
The most recent analyst rating on (GB:GSK) stock is a Hold with a £20.00 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.
Spark’s Take on GB:GSK Stock
According to Spark, TipRanks’ AI Analyst, GB:GSK is a Neutral.
The score is driven primarily by strong profitability and improving recent fundamentals, supported by constructive 2026 guidance and pipeline momentum. Valuation is reasonable with a modest yield, while the main constraint is technical overbought risk and ongoing balance-sheet/earnings-consistency considerations.
To see Spark’s full report on GB:GSK stock, click here.
More about GlaxoSmithKline
GSK plc is a global biopharmaceutical company focused on developing, manufacturing, and marketing prescription medicines, vaccines, and consumer healthcare products. The group targets major therapeutic areas including respiratory, HIV, immunology, and oncology, with a strong presence in both developed and emerging markets and a primary listing on the London Stock Exchange.
Average Trading Volume: 8,707,514
Technical Sentiment Signal: Buy
Current Market Cap: £87.35B
See more data about GSK stock on TipRanks’ Stock Analysis page.